SCHEMBL31338779

SCHEMBL31338779

COC1(Cc2cccc(F)c2)CCN(C(=O)OC(C)(C)C)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 1/20 0.51
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
TACR1 P25103 1/20 0.44
CCNT1 O60563 1/20 0.44
CYP1A2 P05177 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C19 P33261 1/20 0.43
ALDH1A1 P00352 2/20 0.42
OPRD1 P41143 2/20 0.42
OPRK1 P41145 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.41
CYP46A1 Q9Y6A2 1/20 0.41
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC2 Q92769 1/20 0.40
GRM5 P41594 1/20 0.40
GRM1 Q13255 1/20 0.40
CDK9 P50750 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22265595 1.00 GPR119 (0.51) GPR119MEN1KMT2ATACR1CCNT1
SCHEMBL22265462 0.86 GPR119 (0.52) GPR119MEN1KMT2ATACR1CCNT1
SCHEMBL8111848 0.86 GPR119 (0.52) GPR119MEN1KMT2ATACR1CCNT1
SCHEMBL4634595 0.86 KDM1A (0.46) MEN1KMT2ATACR1OPRD1OPRK1
SCHEMBL2952979 0.86 OPRD1 (0.51) GPR119TACR1OPRD1OPRK1CYP46A1
SCHEMBL23365157 0.85 KMT2A (0.47) MEN1KMT2ACYP1A2CYP2D6CYP2C19
SCHEMBL22309112 0.84 MEN1 (0.51) GPR119MEN1KMT2ATACR1CCNT1
SCHEMBL22309108 0.81 MEN1 (0.68) GPR119MEN1KMT2AALDH1A1L3MBTL1
SCHEMBL8117309 0.80 GPR119 (0.51) GPR119MEN1KMT2ATACR1CCNT1
SCHEMBL8101993 0.80 GPR119 (0.51) GPR119MEN1KMT2ATACR1CCNT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250034124-A1 COMPOUNDS AND USES THEREOF JANSSEN PHARMACEUTICA NV (BE) 2025-01-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250034124-A1 COMPOUNDS AND USES THEREOF NLN, BDNF, NQO1 GPR119 3998/4885MEN1 191/4885KMT2A 587/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.